share_log

EF Hutton Maintains Buy on ISpecimen, Lowers Price Target to $4.25

EF Hutton Maintains Buy on ISpecimen, Lowers Price Target to $4.25

EF Hutton 維持對iSpecimen的買入,將目標股價下調至4.25美元
Benzinga Real-time News ·  2022/09/23 10:52

EF Hutton analyst Constantine Davides maintains iSpecimen (NASDAQ:ISPC) with a Buy and lowers the price target from $5.5 to $4.25.

EF Hutton分析師康斯坦丁·戴維斯維持iSpecimen(納斯達克股票代碼:ISPC)的買入,並將目標股價從5.5美元下調至4.25美元。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論